Rigel Pharmaceuticals Inc (RIGL)
R&D Expenses
$13.96M
Quarterly · Period ending: · USD
RIGL R&D Expenses
Latest reported$13.96Mperiod ending
Latest reported$13.96Mperiod ending
RIGL Quarterly R&D Expenses ($0.00 → $13.96M)
Quarterly R&D Expenses
High-resolution chart · PNG
RIGL r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 8,787,000 | |
| 5,977,000 | |
| 32,034,000 | |
| 0 | |
| 0 | |
| 0 |